Dr-Catherine-Lord-Awarded-Sarnat-Prize-Mental-Health-Research
Dr. Catherine Lord, director of the Center for Autism and the Developing Brain, a collaboration between Weill Cornell Medicine, NewYork-Presbyterian, and Columbia University College of Physicians and Surgeons, received the prestigious Rhoda and Bernard Sarnat International Prize in Mental Health from the National Academy of Medicine.
NonChemo-Drugs-for-Mantle-Cell-Lymphoma-is-Worth-Continued-Study
Newer, non-chemotherapy drugs benefit many patients with mantle cell lymphoma (MCL), an incurable form of blood cancer, and deserve deeper study in clinical trials, according to an editorial published Sept. 12 in Blood by scientists at NewYork-Presbyterian and Weill Cornell Medicine.
NYP-Brooklyn-Methodist-Welcomes-New-Years-Baby-2018
At 6:49 am on January 1, NewYork-Presbyterian Brooklyn Methodist Hospital welcomed its New Year’s Baby, Aarya Datar.
WC-NYP-Makes-Rec-for-Treatment-of-Congenital-Heart-Defect-Stroke
Young people with a history of strokes caused by blood clots should be evaluated for a congenital condition characterized by a hole in the heart. If present, surgical closure should be considered to prevent future stroke, according to an editorial by a Weill Cornell Medicine and NewYork-Presbyterian neurologist.
Cancer-Immunotherapy-Work-Better-in-Patients-with-Specific-Genes
Cancer cells arise when DNA is mutated, and these cells should be recognized as “foreign” by the immune system. However, cancer cells have found ways to evade detection by the immune system. New drugs called immune checkpoint inhibitors can restore the immune system’s recognition of cancer cells and have led to dramatic responses in a number of cancer types.
NYP-Brooklyn-Methodist-Hospital-Cuts-the-Ribbon
On February 23, the ribbon on NewYork-Presbyterian Brooklyn Methodist Hospital was officially cut, with NewYork-Presbyterian and NYP Brooklyn Methodist leadership, local officials and members of the community in attendance. In addition to the ceremonial ribbon cutting, the event featured a brief program of speeches.
MSCH-Achieves-National-Accreditation-from-the-MBSAQIP
NewYork-Presbyterian Morgan Stanley Children’s Hospital has been accredited under the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP), a joint program of the American College of Surgeons and the American Society for Metabolic and Bariatric Surgery, in the treatment of pediatric bariatric surgical patients. NewYork-Presbyterian Morgan Stanley Children’s Hospital is the only stand-alone children’s hospital in New York State to hold this designation, accredited as an Adolescent Center, and one of only six in the nation.
Signs-of-AML-May-Be-Present-Years-Before-Diagnosis
Patients with acute myeloid leukemia (AML) may have genetic mutations in their blood indicating they are at high risk of developing the disease about nine years before diagnosis, according to research from Weill Cornell Medicine and NewYork-Presbyterian investigators. They presented their findings at the 59th annual American Society of Hematology meeting on Dec. 10 in Atlanta, Ga.
Page61 of 333